Unexpectedly, and of great interest, it is our observation that the inhibition of TrxR1 alone by NHC-Gold complexes, such as Au3BC, is not sufficient to induce cell death, as cancer cells activated pro-survival pathways to escape the pharmacological treatment. The gene discussed is TXNRD1; the disease is cancer.